X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9096) 9096
Publication (1128) 1128
Book Review (976) 976
Book Chapter (22) 22
Conference Proceeding (9) 9
Dissertation (9) 9
Magazine Article (6) 6
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8503) 8503
humans (5676) 5676
animals (4582) 4582
pyrazoles - pharmacology (4328) 4328
male (4312) 4312
female (2929) 2929
pyrazoles - therapeutic use (2518) 2518
rats (2120) 2120
mice (1700) 1700
middle aged (1544) 1544
pharmacology & pharmacy (1533) 1533
pyrazoles - administration & dosage (1528) 1528
celecoxib (1347) 1347
aged (1320) 1320
adult (1279) 1279
pyrazoles - adverse effects (1169) 1169
oncology (1084) 1084
hematology (1010) 1010
dose-response relationship, drug (961) 961
abridged index medicus (884) 884
treatment outcome (831) 831
pyrazoles (804) 804
pyrimidines - pharmacology (723) 723
sulfonamides - pharmacology (713) 713
pyrazoles - chemistry (684) 684
rats, sprague-dawley (683) 683
analysis (675) 675
expression (661) 661
time factors (638) 638
cancer (633) 633
piperidines - pharmacology (624) 624
pyrazoles - pharmacokinetics (621) 621
administration, oral (613) 613
cell line, tumor (613) 613
article (600) 600
care and treatment (566) 566
research (565) 565
disease models, animal (560) 560
sulfonamides - therapeutic use (554) 554
biochemistry & molecular biology (549) 549
chemistry, medicinal (531) 531
rats, wistar (523) 523
neurosciences (504) 504
aged, 80 and over (495) 495
activation (478) 478
drug therapy (465) 465
medicine & public health (452) 452
cell biology (442) 442
pyridines - pharmacology (430) 430
apoptosis (425) 425
signal transduction - drug effects (425) 425
cardiac & cardiovascular systems (416) 416
risk factors (415) 415
mice, inbred c57bl (412) 412
pyrimidines - therapeutic use (407) 407
health aspects (400) 400
cells, cultured (388) 388
cyclooxygenase inhibitors - pharmacology (387) 387
inhibition (382) 382
structure-activity relationship (382) 382
inflammation (378) 378
apoptosis - drug effects (375) 375
pyrazoles - blood (374) 374
protein kinase inhibitors - pharmacology (373) 373
rodents (373) 373
protein kinase inhibitors - therapeutic use (368) 368
anticoagulants (367) 367
rivaroxaban (366) 366
pyrazoles - chemical synthesis (361) 361
receptor, cannabinoid, cb1 - antagonists & inhibitors (361) 361
pyridones - therapeutic use (359) 359
cox-2 inhibitors (357) 357
sulfonamides - adverse effects (357) 357
nonsteroidal antiinflammatory drugs (356) 356
in-vitro (353) 353
therapy (353) 353
cells (351) 351
cell proliferation - drug effects (350) 350
dabigatran (350) 350
double-blind method (348) 348
peripheral vascular disease (334) 334
dogs (333) 333
mutation (331) 331
blood pressure - drug effects (330) 330
sulfonamides - administration & dosage (325) 325
signal transduction (323) 323
in vitro techniques (321) 321
physiological aspects (321) 321
apixaban (319) 319
antineoplastic agents - therapeutic use (317) 317
antineoplastic agents - pharmacology (316) 316
safety (314) 314
inhibitors (313) 313
toxicology (313) 313
brain (312) 312
medicine, general & internal (308) 308
endocrinology & metabolism (304) 304
anticoagulants - therapeutic use (301) 301
pharmacokinetics (294) 294
physiology (291) 291
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8859) 8859
German (88) 88
French (36) 36
Japanese (29) 29
Russian (25) 25
Italian (22) 22
Spanish (19) 19
Chinese (14) 14
Czech (9) 9
Norwegian (4) 4
Polish (4) 4
Dutch (3) 3
Hungarian (3) 3
Swedish (3) 3
Danish (2) 2
Finnish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke, ISSN 0039-2499, 01/2015, Volume 46, Issue 1, pp. 237 - 244
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2005, Volume 353, Issue 20, pp. 2121 - 2134
Rimonabant is a selective cannabinoid-1 receptor blocker. In this clinical trial, the drug was found to result in moderate weight loss and improvement in... 
C-REACTIVE PROTEIN | BODY-FAT | MEDICINE, GENERAL & INTERNAL | ADIPONECTIN | PLASMA-LIPOPROTEIN | MEN | WEIGHT-LOSS | CANNABINOID CB1 RECEPTOR | VISCERAL OBESITY | ASSOCIATION | CARDIOVASCULAR RISK | Pyrazoles - therapeutic use | Dyslipidemias - complications | Obesity - drug therapy | Cannabinoid Receptor Antagonists | Cholesterol - blood | Humans | Middle Aged | Anti-Obesity Agents - adverse effects | Male | Weight Loss - drug effects | Insulin - blood | Obesity - blood | Anti-Obesity Agents - therapeutic use | Overweight | Dyslipidemias - blood | Leptin - blood | Adult | Female | Pyrazoles - adverse effects | Dyslipidemias - drug therapy | Double-Blind Method | Obesity - complications | Risk Factors | Metabolic Syndrome - complications | Adiponectin - blood | Blood Glucose - drug effects | Piperidines - therapeutic use | Piperidines - adverse effects | Triglycerides - blood | Aged | Overweight persons | Obesity | Care and treatment | Research | Health aspects | Body weight | Cardiovascular disease | Weight control | Diet | Cholesterol | Index Medicus | Abridged Index Medicus | Dyslipidemias | Metabolic Syndrome X | MEDICIN OCH HÄLSOVETENSKAP | Cannabinoid | Adiponectin | Receptors | Piperidines | MEDICAL AND HEALTH SCIENCES | drug therapy | complications | Pyrazoles | Blood Glucose | drug effects | Triglycerides | blood | Insulin | antagonists & inhibitors | Anti-Obesity Agents | Weight Loss | Leptin | adverse effects | therapeutic use
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2007, Volume 50, Issue 22, pp. 5339 - 5356
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2007, Volume 5, Issue 12, pp. 2376 - 2385
Background:  Selective inhibitors of cyclooxygenase‐2 (COX‐2) called coxibs, are effective anti‐inflammatory and analgesic drugs. Recently, these drugs were... 
thromboxane | coxibs | thrombin generation | prostacyclin | NSAID | platelet activation | Thrombin generation | Prostacyclin | Platelet activation | Thromboxane | Coxibs | MASS-SPECTROMETRY | CYCLOOXYGENASES | ANTIPLATELET | THROMBOMODULIN | CLOPIDOGREL | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | EXPRESSION | IONIZATION | TISSUE FACTOR | Humans | Naproxen - pharmacology | Sulfones - adverse effects | Male | Reference Values | Blood Platelets - enzymology | Sulfones - pharmacology | Prostaglandins - blood | Lactones - pharmacology | Phospholipases A - blood | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Cyclooxygenase 2 - blood | Time Factors | Prostaglandins - urine | Pyrazoles - blood | Antigens, Neoplasm - blood | Adult | Platelet Aggregation - drug effects | Cyclooxygenase 2 Inhibitors - blood | Blood Platelets - drug effects | Sulfones - blood | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Thrombomodulin - blood | Naproxen - adverse effects | Cyclic AMP - blood | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Celecoxib | Lactones - adverse effects | Cell Adhesion - drug effects | Naproxen - blood | Sulfonamides - pharmacology | Thromboxanes - blood | Thromboxanes - urine | Blood Platelets - metabolism | Fibrinogen - metabolism | P-Selectin - blood | Sulfonamides - adverse effects | Leukocytes - drug effects | Platelet Activation - drug effects | Thrombin - metabolism | Platelet Membrane Glycoprotein IIb - blood | Physiological aspects | Prothrombin | COX-2 inhibitors | Thrombin | Analysis | Index Medicus
Journal Article
Journal Article
FASEB Journal, ISSN 0892-6638, 03/2006, Volume 20, Issue 3, pp. 542 - 544
It is widely believed that the potencies of nonsteroid anti-inflammatory drugs ( NSAIDs) as inhibitors of cyclooxygenase ( COX) are influenced by protein... 
SITE | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | nonsteroid anti-inflammatory drugs | coxibs | PROSTAGLANDIN H-2 SYNTHASE | CELL BIOLOGY | CYCLO-OXYGENASE-2 | THERAPY | FLUID | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | BIOLOGY | prostaglandins | SELECTIVITY | Organic Chemicals - cerebrospinal fluid | Humans | Naproxen - pharmacology | Synovial Fluid - metabolism | Pyrazoles - cerebrospinal fluid | Sodium Salicylate - pharmacology | Lactones - pharmacology | Aspirin - cerebrospinal fluid | Cell Line - drug effects | Calcium - physiology | Pyrazoles - blood | Organic Chemicals - pharmacology | Dinoprostone - cerebrospinal fluid | Diclofenac - cerebrospinal fluid | Aspirin - pharmacology | Sulfones - cerebrospinal fluid | Aspirin - blood | Thiazines - blood | Sulfonamides - pharmacology | Indomethacin - cerebrospinal fluid | Indomethacin - pharmacology | Cyclooxygenase 1 - drug effects | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - blood | Diclofenac - pharmacology | Thiazoles - blood | Thromboxane A2 - blood | Cerebrospinal Fluid Proteins - pharmacology | Dinoprostone - biosynthesis | Lactones - cerebrospinal fluid | Blood Platelets - enzymology | Cyclooxygenase 2 Inhibitors - cerebrospinal fluid | Sodium Salicylate - cerebrospinal fluid | Sulfones - pharmacology | Blood Proteins - pharmacology | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Naproxen - cerebrospinal fluid | Sodium Salicylate - blood | Thiazines - pharmacology | Cyclooxygenase 2 Inhibitors - blood | Cyclooxygenase Inhibitors - cerebrospinal fluid | Blood Platelets - drug effects | Sulfones - blood | Organic Chemicals - blood | Ionophores - pharmacology | Pyrazoles - pharmacology | Sulfonamides - cerebrospinal fluid | Cyclooxygenase 2 Inhibitors - pharmacology | Thiazoles - cerebrospinal fluid | Celecoxib | Diclofenac - blood | Dinoprostone - blood | Naproxen - blood | Organ Specificity | Calcimycin - pharmacology | Cyclooxygenase Inhibitors - pharmacology | Indomethacin - blood | Protein Binding | Thiazines - cerebrospinal fluid | Thiazoles - pharmacology | Index Medicus
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2017, Volume 15, Issue 3, pp. 565 - 574
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2009, Volume 29, Issue 3, pp. 416 - 423
Background-Rimonabant, the first selective cannabinoid type 1 (CB1) receptor antagonist, improves cardiometabolic risk factors in overweight/obese patients.... 
Cardiometabolic risk | Intraabdominal obesity | Liver fat | Rimonabant | Dyslipidemia | C-REACTIVE PROTEIN | cardiometabolic risk | rimonabant | METABOLIC SYNDROME | CANNABINOID-1 RECEPTOR BLOCKER | MYOCARDIAL-INFARCTION | WEIGHT-LOSS | RANDOMIZED CONTROLLED-TRIAL | CARDIOMETABOLIC RISK-FACTORS | ABDOMINAL OBESITY | liver fat | CARDIOVASCULAR-DISEASE | OVERWEIGHT PATIENTS | intraabdominal obesity | PERIPHERAL VASCULAR DISEASE | dyslipidemia | HEMATOLOGY | Pyrazoles - therapeutic use | Obesity - drug therapy | Humans | Middle Aged | Body Weight - drug effects | Anti-Obesity Agents - adverse effects | Male | Tomography, X-Ray Computed | Insulin - blood | Obesity - blood | Anti-Obesity Agents - therapeutic use | Dyslipidemias - blood | C-Reactive Protein - metabolism | Liver - drug effects | Time Factors | Liver - diagnostic imaging | Adult | Female | Blood Pressure - drug effects | Intra-Abdominal Fat - drug effects | Pyrazoles - adverse effects | Dyslipidemias - drug therapy | Adiposity - drug effects | Double-Blind Method | Liver - metabolism | Obesity - physiopathology | Treatment Outcome | Apolipoproteins - blood | Intra-Abdominal Fat - metabolism | Adiponectin - blood | Blood Glucose - drug effects | Intra-Abdominal Fat - diagnostic imaging | Piperidines - therapeutic use | Piperidines - adverse effects | Triglycerides - blood | Cholesterol, HDL - blood | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Lipoproteins, LDL - blood | Dyslipidemias - physiopathology | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0171486 - e0171486
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 05/2015, Volume 139, Issue 5, pp. 665 - 673
Journal Article
Oncotarget, ISSN 1949-2553, 01/2016, Volume 7, Issue 1, pp. 1066 - 1075
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article